Rhon-klinikum Ag · XETR:RHK

Rhon-klinikum — 9M 2015 Earnings Presentation

10 slides from Rhon-klinikum's earnings presentation, Nov 6, 2015

  1. Slide 1: Results for the First Nine Months of 2015

    RHÖN-KLINIKUM AG Results for the First Nine Months of 2015 November 6, 2015 Jens-Peter Neumann, CFO Dr. Kai G. Klinger

  2. Slide 2: Disclaimer

    Disclaimer  This document has been prepared by RHÖN-KLINIKUM AG (“RHÖN-KLINIKUM” or “the Company”) for information purposes only, solely for use during this presentation. It must be treated confidentially by attendees at such presentation and must not be distributed, passed on or otherwise disclose

  3. Slide 3: Key Events of Third Quarter 2015

    Key Events of Third Quarter 2015 Another quarter with resilient organic growth figures ...  Attractive volume increase with +1.7% more DRG case-mix-points in first 9 months; in total an 8.1% rise in inpatient and outpatient cases to 569,978  Improvement of case mix index (average severity per case

  4. Slide 4: Key P&L Figures for First Nine Months of 2015

    Key P&L Figures for First Nine Months of 2015 Performance * 9m 2015 Decent operating performance in € millions  Despite typical seasonality of Q3 revenue, Revenue 832 100.0% development clearly in-line with organic growth target of 3-4% Personnel expenses -527 63.3%  Higher case mix index leads to

  5. Slide 5: Successful Execution of 2015 Share Repurchase Offer and Subsequent Capital Reduction

    Successful Execution of 2015 Share Repurchase Offer and Subsequent Capital Reduction Objectives of the share repurchase offer Like-for-like shareholder structure  Tax efficient distribution of another portion of the proceeds after capital reduction from Fresenius/HELIOS transaction as of November 6

  6. Slide 6: Core Balance Sheet Figures as of September 30, 2015

    Core Balance Sheet Figures as of September 30, 2015 € 1,775m € 1,775m € 837m Non-current assets 47.2% € 1,072m 60.4% Equity Equity ratio € 687m cash € 35m non-current liabilities 2.0% € 156m financial debt € 938m 52.8% € 667m Current assets 37.6% Current liabilities Assets Equity & Liabilities  Net

  7. Slide 7: Improvement of Management Structure

    Improvement of Management Structure Prof. Dr. Bernd Griewing joins management board  From January 1, 2016 as Chief Medical Officer  >15 years‘ experience as chief physician in neurology and medical director of Campus Bad Neustadt  Member of supervisory board of UKGM since 2006  Spokesperson for

  8. Slide 8: Outlook 2015 and Regulatory Changes

    Outlook 2015 and Regulatory Changes General wage sum increase as main reference First impetus from 2016 pricing ... number for price negotiations (initial DRG inflator)  +2.95% as initial DRG inflator for 2016 3.0% 2.8% 2.95% 2.5%  Actual state base rates to be negotiated in Q1 2.0% 2.0% 2.0% 1.4%

  9. Slide 9: Appendix: Financial Calendar

    Appendix: Financial Calendar FY 2016  February 26, 2016 Preliminary results for financial year 2015  April 15, 2016 Press conference: publication of annual financial report 2015  May 6, 2016 Publication of interim report for the quarter ending March 31, 2016  June 8, 2016 Annual General Meeting

  10. Slide 10: Appendix: Price Regulation at a Glance

    Appendix: Price Regulation at a Glance Average base rate increase in states with RHÖN hospitals Federal Total hospital system budget (weighted by RHÖN case mix) Level  Wage sum increase as main reference number for RHÖN effective base rate Benchmark (wage sum) Layer 1 DRG inflation in 2016: +2.95 (

Rhön-Klinikum — 9M 2015 Earnings Presentation on 6ix